NovaBridge Biosciences Prepaid Expense and Other Assets, Current
NovaBridge Biosciences (NBP) had Prepaid Expense and Other Assets, Current of $6.68 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-04-07
- 2023-12-31: Prepaid Expense and Other Assets, Current 52.00M CNY.
- 2022-12-31: Prepaid Expense and Other Assets, Current 80.28M CNY.
- 2022-06-30: Prepaid Expense and Other Assets, Current 101.00M CNY.
- 2021-12-31: Prepaid Expense and Other Assets, Current 190.82M CNY.
CNY
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2023-12-31 | 52.00M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 80.28M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 101.00M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 190.82M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 195.47M CNY 20-F · filed 2022-04-29 |
| 2020-09-30 | 219.84M CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | 136.04M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 88.97M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $6.68M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $4.50M 6-K · filed 2025-12-18 | |
| 2025-06-30 | $2.03M 6-K · filed 2025-10-06 | |
| 2024-12-31 | $3.29M 20-F · filed 2026-04-07 | |
| 2023-12-31 | $2.50M 20-F · filed 2025-04-03 | $7.33M 20-F · filed 2024-04-30 |
| 2022-12-31 | $11.64M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $15.08M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $29.94M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $29.96M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $32.38M 6-K · filed 2021-02-05 | |
| 2019-12-31 | $19.54M 20-F · filed 2020-04-29 |